Horizon Therapeutics Public Ltd Co

Russell Investments Group, Ltd.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

133,657

Value ($000)

15,463

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	15,463	0.0%	133,657	9/30/2023
2023 Q2	8/10/2023	15,536	0.0%	151,056	6/30/2023
2023 Q1	5/9/2023	44,891	0.1%	411,319	3/31/2023
2022 Q4	2/8/2023	53,438	0.1%	469,575	12/31/2022
2022 Q3	11/4/2022	32,902	0.1%	531,655	9/30/2022
2022 Q2	7/29/2022	9,519	0.0%	119,301	6/30/2022
2022 Q1	5/5/2022	13,929	0.0%	132,291	3/31/2022
2021 Q4	1/21/2022	14,333	0.0%	132,978	12/31/2021
2021 Q3	11/8/2021	15,349	0.0%	140,106	9/30/2021
2021 Q2	8/4/2021	11,665	0.0%	124,516	6/30/2021
2021 Q1	5/10/2021	6,982	0.0%	76,011	3/31/2021
2020 Q4	2/8/2021	3,883	0.0%	53,186	12/31/2020
2020 Q3	11/9/2020	6,442	0.0%	82,943	9/30/2020
2020 Q2	8/5/2020	4,752	0.0%	85,548	6/30/2020
2020 Q1	5/6/2020	5,155	0.0%	174,373	3/31/2020
2019 Q4	1/29/2020	17,551	0.0%	485,216	12/31/2019